- Global Pharma News & Resources

Burn Care Market Foreseen Projected to Exceed US$ 3,539.5 Million Threshold by 2026 | CAGR: 6.1%: Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global burn care market, which was assessed at US$ 2,219 million in 2018, is now projected to expand significantly over the forecast period (2019-2026), with an impressive 6.1% CAGR.

Get FREE Sample PDF Including COVID-19 Impact Analysis:

Increasing product approvals and technological advancements in the treatments of moderate-to-severe burns are likely to foster the global burn care market growth over the projected period. In September 2018, Avita Medical Americas LLC received the Premarket Approval (PMA) application by the U.S. Food and Drug Administration (FDA) for its RECELL Autologous Cell Harvesting Device (RECELL System) intended for the treatment of severe thermal burns of patients, aged 18 years and above. Other innovative techniques, such as the electrospinning technology, are also being widely adopted across the globe. For instance, the portable electrospinning technology enhances the inherent characteristics of electrospun nanofibers, mimicking the structure of the body tissue. It offers an excellent medium for tissue integration and regeneration, while significantly facilitating the healing process.

Browse Press Release:

Key Takeaways of the Global Burn Care Market:

  • Among the various product types, the advanced burn care segment is expected to acquire a major revenue share in the global burn care market in 2026.
  • The major players operating in the global burn care market include Smith & Nephew Plc. Molnlycke, ConvaTec Inc., Integra LifeSciences Corporation, 3M, Coloplast A/S, Cardinal Health, Inc., DeRoyal Industries, Inc., Acelity LP, and Svenska Cellulosa Aktiebolaget (SCA).
  • The key market players are deeply focused on formulating new skin graft technologies. For instance, in April 2019, Mallinckrodt Plc. announced that Stratatech, a Mallinckrodt company, completed patient enrollment in its ongoing pivotal Phase 3 clinical trial of StrataGraft, which is an investigational regenerative skin tissue. The multicenter study assessed the efficacy and safety of StrataGraft in the promotion of autologous skin regeneration of complex skin defects. Furthermore, in March 2018, Ireland-based research center Curam brought forward a multidisciplinary healthcare approach, known as the NanoGrowSkin Project, in a bid to develop novel therapies and technologies in skin regeneration for the treatment of burns and chronic wounds.

Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737


This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 05-Oct-2020